氯胺酮在急诊科急性激越初始控制中的疗效:一项随机研究
本研究为前瞻性、单机构、随机、开放标签、真实世界、标准诊疗的预试验,纳入93例好斗性激越的急诊成人患者,随机接受氯胺酮(4 mg/kg IM 或 1 mg/kg IV)或氟哌啶醇/劳拉西泮(氟哌啶醇5-10 mg IM或IV + 劳拉西泮1-2 mg IM或IV)。主要终点为5分钟内镇静,氯胺酮组22% vs 氟哌啶醇/劳拉西泮组0%(p=0.001);15分钟内镇静率66% vs 7%(p<0.001);中位镇静时间15 vs 36分钟(p<0.001)。氯胺酮组出现一过性心动过速(p=0.01)和高血压(p=0.01)。结论认为,对于好斗性激越患者,氯胺酮在急性激越初始控制方面显著优于氟哌啶醇/劳拉西泮,且未伴有任何显著不良反应。
要点
- 好斗性激越的急诊成人患者中,氯胺酮(4 mg/kg IM 或 1 mg/kg IV)5分钟内镇静率22%,氟哌啶醇/劳拉西泮组为0%(p=0.001)。
- 氯胺酮15分钟内镇静率66%,显著高于氟哌啶醇/劳拉西泮组的7%(p<0.001)。
- 氯胺酮组中位镇静时间为15分钟,氟哌啶醇/劳拉西泮组为36分钟(p<0.001)。
- 氯胺酮组出现显著但一过性的心动过速(p=0.01)和高血压(p=0.01),未报告其他显著不良反应。
- 本研究为单机构、随机、开放标签、真实世界、标准诊疗的预试验,样本量93例,结论需在更大样本中验证。
适用人群与场景
- 急诊科成人好斗性激越患者。
处置流程与药物剂量
- 氯胺酮组:氯胺酮4 mg/kg IM或1 mg/kg IV。
- 氟哌啶醇/劳拉西泮组:氟哌啶醇5-10 mg IM或IV联合劳拉西泮1-2 mg IM或IV。
研究设计与关键结果
- 研究类型:前瞻性、单机构、随机、开放标签、真实世界、标准诊疗的预试验;样本量93例;人群:急诊成人好斗性激越患者;干预:氯胺酮(4 mg/kg IM或1 mg/kg IV)vs 氟哌啶醇/劳拉西泮(氟哌啶醇5-10 mg IM或IV + 劳拉西泮1-2 mg IM或IV)。
- 主要终点:5分钟内镇静率氯胺酮组22% vs 氟哌啶醇/劳拉西泮组0%(p=0.001)。
- 关键次要终点:15分钟内镇静率氯胺酮组66% vs 氟哌啶醇/劳拉西泮组7%(p<0.001);中位镇静时间氯胺酮组15分钟 vs 氟哌啶醇/劳拉西泮组36分钟(p<0.001)。
- 不良事件:氯胺酮组出现显著但一过性心动过速(p=0.01)和高血压(p=0.01);未报告其他显著不良反应。
证据类型、等级与局限
- 证据类型:前瞻性、单机构、随机、开放标签、真实世界、标准诊疗的预试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于急诊科好斗性激越的成人患者,与氟哌啶醇/劳拉西泮相比,氯胺酮(4 mg/kg IM或1 mg/kg IV)可能更快速地实现初始镇静,5分钟内和15分钟内镇静率更高,中位镇静时间更短。
- 氯胺酮组可能出现一过性心动过速和高血压,需在床旁监测中予以关注。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Clinicians often encounter agitated patients, and current treatment options include benzodiazepines and antipsychotics. Ketamine rapidly induces dissociation, maintains cardiovascular stability, spontaneous respirations, and airway reflexes. There are no prospective, randomized studies comparing ketamine to other agents in the initial management of acute agitation in the Emergency Department (ED).
OBJECTIVE: Determine the efficacy and safety of ketamine compared to parenteral haloperidol plus lorazepam for initial control of acute agitation.
METHODS: This study was a prospective, single-institution, randomized, open-label, real world, standard of care pilot study. Adult patients with combative agitation were randomized to ketamine (4 mg/kg IM or 1 mg/kg IV) or haloperidol/lorazepam (haloperidol 5-10 mg IM or IV + lorazepam 1-2 mg IM or IV). The primary outcome was sedation within 5 min, and secondary outcomes included sedation within 15 min, time to sedation, and safety.
RESULTS: Ninety three patients were enrolled from January 15, 2018 to October 10, 2018. Significantly more patients who received ketamine compared to haloperidol/lorazepam were sedated within 5 min (22% vs 0%, p = 0.001) and 15 min (66% vs 7%, p < 0.001). The median time to sedation in patients who received ketamine compared to haloperidol/lorazepam was 15 vs 36 min respectively (p < 0.001). Patients who received ketamine experienced a significant, but transient tachycardia (p = 0.01) and hypertension (p = 0.01).
CONCLUSION: In patients with combative agitation, ketamine was significantly more effective than haloperidol/lorazepam for initial control of acute agitation, and was not associated with any significant adverse effects.
参考来源
- Lin J, Figuerado Y, Montgomery A, et al. Efficacy of ketamine for initial control of acute agitation in the emergency department: A randomized study. Am J Emerg Med. 2020. PMID: 32340820. doi:10.1016/j.ajem.2020.04.013
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。